Work

Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice

Year: 2012
Type: article
Abstract: In neurodegenerative disorders, abnormally hyperphosphorylated and aggregated tau accumulates intracellularly, a mechanism which is thought to induce neuronal cell death. Methylene blue, a type of phenothiazine, has been reported to inhibit tau aggregation in vitro. However, the effect of methylene blue in vivo has remained unknown. Therefore, we examined whether methylene blue suppresses abnormal tau accumulation using P301L tau transgenic mice. At 8 to 11 months of age, these mice were orally administered methylene blue for 5 months. Subsequent results of Western blotting analysis revealed that this agent reduced detergent-insoluble phospho-tau. Methylene blue may have potential as a drug candidate for the treatment of tauopathy.
Source: PLoS ONE
Language: English
Open Access status: gold
Estimated APC paid: $2,382
OpenAlex ID: W2071013059
FWCI: 2.579
Cites: 26
Cited by: 102
Related to: 10
Parts: 6